|
A Diagnostic to Determine Sensitivity to Pharmaceutical Oxytocin and Risk of Postpartum Blood Loss based on Genetic and/or Epigenetic Factors
This invention is for a genetic polymorphism test for assessing the risk of postpartum hemorrhage (PPH) and consequently the need for pharmacological oxytocin. This novel test uses a blood or saliva sample to identify key epigenetic variants linked to oxytocin receptor gene function, ultimately allowing for assessment of responsiveness to the medication.
Background:...
Published: 8/20/2024
|
Inventor(s): Elise Erickson, Jessica Connelly
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Reproductive Health: Obstetrics & Gynecology, Technology Classifications > Healthcare Portfolios > Women's Health, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Medical Devices > Diagnostic
|
